Boothbay Fund Management »

4d Molecular Therapeutics In shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.8M 150k 31.86

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ishares Bitcoin Tr SHS (IBIT)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Grayscale Bitcoin Tr Btc Shs Rep Com Ut (GBTC)
Microstrategy Cl A New Put Option (MSTR)
Bitwise Bitcoin Etf Tr Shs Ben Int (BITB)
Sarepta Therapeutics Put Option (SRPT)
Spdr Ser Tr S&p Biotech Put Option (XBI)
United States Steel Corporation (X)
NVIDIA Corporation Call Option (NVDA)
Cornerstone Strategic Value (CLM)
Amazon Put Option (AMZN)
Humana Call Option (HUM)
Amphenol Corp Cl A Put Option (APH)

View all positions for Boothbay Fund Management

Top funds holding 4d Molecular Therapeutics In

RA Capital Management
BlackRock
VR Adviser
Goldman Sachs Group
Deep Track Capital
BVF
Henderson Group
Viking Global Investors
Vanguard Group
State Street Corporation
Polar Capital Holdings
Morgan Stanley
Novo A/S
Redmile Group
Geode Capital Management

View all funds holding 4d Molecular Therapeutics In